Lacy John III 4
4 · PROVECTUS BIOPHARMACEUTICALS, INC. · Filed Nov 12, 2020
Insider Transaction Report
Form 4
Lacy John III
Director
Transactions
- Award
Common Stock
2020-11-10+100,000→ 200,000 total - Award
Stock Options (Right to Buy)
2020-11-10+100,000→ 100,000 totalExercise: $0.29From: 2020-11-10Exp: 2025-11-10→ Common Stock (100,000 underlying)
Holdings
- 450(indirect: By Spouse)
Common Stock